Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Hires at Integrated Diagnostics and More

Premium

Integrated Diagnostics announced this week that it has appointed Donald Seaton as chief financial officer and James Garner as chief business officer (See story this issue).

Seaton was previously chief financial officer at several life science companies including EndoGastric Solutions, Corus Pharma, Talisma, SonoSite, and InControl.

Garner, who worked with InDi for most of 2011 as a consultant, was previously an executive at UnitedHealth Group as well as vice president of sales at MDatactor and director of marketing at Elan Diagnostics.


Bruker this week announced it has appointed Stephan Westermann as executive vice president for order execution, production, and logistics of its Scientific Instruments division.

Previously Westermann was executive vice president of operations for Bruker BioSpin. Before that he was chief financial officer of Bruker AXS and Bruker BioSpin.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.